Grigoris Gerotziafas: The Evolving Landscape of Genetic Risk Assessment in VTE
Grigoris Gerotziafas, Director of the Cancer, Vessels, Biology, and Therapeutics (CaVITE) Research Department, Head of the CRSA at Sorbonne University, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Polish Archives of Internal Medicine, adding:
”The VAS Group is pleased to announce the publication of our latest review article in the Polish Archives of Internal Medicine (PAIM):
‘Inherited thrombophilia and polygenic risk scores in venous thromboembolism: from classical testing to genomic risk prediction’
This is an updated overview of the evolving landscape of genetic risk assessment in venous thromboembolism (VTE), moving from conventional inherited thrombophilia testing toward next-generation genomic and polygenic risk prediction approaches.
Key messages of the review include:
- The complex interaction between genetic, acquired, and environmental determinants of VTE
- The current and future role of classical thrombophilia testing (Factor V Leiden, Prothrombin G20210A, antithrombin, protein C and protein S deficiencies)
- The emergence of genome-wide association studies (GWAS)-derived polygenic risk scores as innovative tools for individualized VTE risk stratification
- The potential integration of genomic medicine into precision thrombosis prevention and management
- The major scientific and clinical barriers that still limit implementation in routine clinical practice
This publication highlights the growing importance of precision medicine and translational vascular science in the management of thrombotic disease.
Congratulations and sincere thanks to all co-authors and collaborators for this excellent international collaborative work.”
Title: Inherited thrombophilia and polygenic risk scores in venous thromboembolism: from classical testing to genomic risk prediction
Authors: Benilde Cosmi, Grigoris Gerotziafas, Peter Marschang, Matija Kozak, Mariella Catalano, Agata Stanek
Stay updated on all scientific advances with Hemostasis Today.
-
May 9, 2026, 14:00Dorcas Gandhi: Telerehabilitation, Low-Cost Robotics in India and AVERT-DOSE Results at ESOC 2026
-
May 9, 2026, 13:50Khaled Musallam: Listening to Patients’ Needs and Challenges Remains the Foundation for a Better Care
-
May 9, 2026, 13:43Matías J Alet: Proud to Present the CAMINA Project on Argentina’s National Stroke Center Mapping at ESOC 2026
-
May 9, 2026, 13:28Maeva May: Stroke Association Is Proud to Support WHO Resolution on Global Stroke Advocacy
-
May 9, 2026, 11:44Somia Iqtadar։ A Meeting with the Scientist Who Helped Transform Anticoagulation
-
May 9, 2026, 11:33Awa Babington-Ashaye: WFH Congress Reflections on Access AI and Patient Care
-
May 9, 2026, 11:23Dirk Sibbing: Why CYP2C19 Genetics Matter in Clopidogrel Response
-
May 9, 2026, 11:19Postpartum Hemorrhage Risk as Remaining Challenge in Hemophilia Carriers – Journal of Thrombosis and Haemostasis
-
May 9, 2026, 11:12Honoring the Legacy of Charles T. Esmon in Hemostasis and Thrombosis – ISTH